Haematotoxicity during peptide receptor radionuclide therapy: Baseline parameters differences and effect on patient's therapy course.

PLoS One · 2021 · PMC8601524 · PMID 34793530

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

The difference with respect to platelet counts was borderline significant ( p value of 0.049) with 262 [IQR 215–342] being the baseline platelet counts for patient with any CTCAE grade 0–1 and 207 [IQR 170–327] for patients with any CTCAE grade 2 haematotoxicity.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.